Xeomin 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFL2T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,014
Award facts
- Contract value 100% obligated
- $24,013.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $24,013.60, was awarded on January 22, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials. The contract is non-competitive and utilizes firm fixed-price pricing, with an ultimate completion date of February 12, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of parent company Cencora, Inc., and operates as a critical pharmaceutical distributor serving federal medical procurement needs across the Department of Defense and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, allowing AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FFL2T?
SPE2DR26FFL2T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FFL2T worth?
The government has obligated $24,014 on SPE2DR26FFL2T.
Is contract SPE2DR26FFL2T an order under another contract?
Yes. SPE2DR26FFL2T is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL2T competed?
The extent of competition for SPE2DR26FFL2T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award